Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Facilitating Activity and Self management in Arthritis (FASA)
ISRCTN ISRCTN66190737
ClinicalTrials.gov identifier
Public title Facilitating Activity and Self management in Arthritis (FASA)
Scientific title Exercise and self-management for people with chronic knee, hip or lower back pain: a study of clinical and cost effectiveness
Acronym FASA
Serial number at source UWE CE10/0817
Study hypothesis 1. To determine whether a generic exercise and self-management intervention delivered to groups of patients with chronic knee, hip or lower back pain can improve function six months post-completion of the intervention
2. To evaluate the acceptability and adherence to the intervention and determine professionals perspectives regarding the intervention
3. To determine the cost-effectiveness of the intervention compared to continued general practitioner (GP) care at six months post-completion of the intervention
Lay summary Lay summary under review
Ethics approval National Research Ethics Service, South West - Southmead approved on 7 July 2011, ref: 11/SW/0053
Study design Cluster randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Chronic musculoskeletal pain and osteoarhritis
Participants - inclusion criteria 1. Aged over 50 years with joint dysfunction
2. Those who have consulted a primary care physician for chronic musculoskeletal degenerative pain of the lower back, hip or knee of at least 6 months duration
Participants - exclusion criteria 1. Lower limb arthroplasty
2. Physiotherapy for associated condition in the preceding 12 months
3. Unstable medical conditions
4. Inability/unwillingness to exercise
5. Wheelchair dependence
6. Non-English speaking (due to pragmatic reasons of cost and engagement with the group intervention)
Anticipated start date 01/12/2011
Anticipated end date 30/11/2014
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 352
Interventions Participants allocated to the intervention arm will receive 6-weeks (twice weekly) group exercise (approximately 8 participants) and self-management based on the ESCAPE programme. In brief, each session lasts for 60-minutes and includes 15-20 minutes of physiotherapist led group discussion and problem-solving session (with supporting handouts) regarding issues of self-management. Topics include activity-rest cycling, use of ice and heat for pain relief, goal-setting and action plans, exercise recommendations and healthy eating and managing changes in pain. After each discussion, participants undertake 35-40 minutes of exercise, based on a circuit of strengthening, aerobic and co-ordination activities. Further to the exercise circuit, in collaboration with the physiotherapist each individual completes an action plan regarding exercise/activities they want to achieve over the following week. This is reviewed after each week, to determine adherence to plan, problem-solving if the goal has proved unachievable, or progressed if achieved. All interventions will be conducted in physiotherapy departments of community/primary care hospitals in Wiltshire. Participants allocated to the continued GP care (control) arm are permitted to continue any current pharmacological or non-pharmacological treatment strategies; furthermore they can be referred for any treatments in primary or secondary care.

Participants will be assessed at baseline, post-intervention and six months later (primary end point)
Primary outcome measure(s) Short musculoskeletal functional assessment
Secondary outcome measure(s) 1. Self-efficacy and exercise health beliefs questionnaire
2. Hospital Anxiety and Depression scale
3. Short Form McGill Pain questionnaire
4. Aggregated Functional Performance Time (AFPT) a combined measure of walking, stair ascent and descent
5. Blood pressure
6. Weight and hip to waist ratio
7. EuroQol EQ-5D self-report generic health status measure (for health related quality of life, and to allow estimation of Quality Adjusted Life Years)
8. Self-reported resource use, (using the framework of the Client Services Receipts Inventory (CSRI) which collects self-reported data across a wide range of items including primary care, hospital care, use of rehabilitation facilities and patient costs)
Sources of funding Chartered Society of Physiotherapy Charitable Trust (UK) (ref: PEP-2010)
Trial website
Publications
Contact name Dr  Nicola  Walsh
  Address Faculty of Health and Life Sciences (HLS)
Glenside Campus
Blackberry Hill
Stapleton
  City/town Brsitol
  Zip/Postcode BS16 1DD
  Country United Kingdom
  Tel +44 (0)117 328 8534
  Fax +44 (0)117 328 8418
  Email nicola.walsh@uwe.ac.uk
Sponsor University of the West of England (UK)
  Address UWE Bristol
Coldharbour Lane
  City/town Bristol
  Zip/Postcode BS16 1QY
  Country United Kingdom
  Email robin.means@uwe.ac.uk
  Sponsor website: http://www.uwe.ac.uk/
Date applied 26/10/2011
Last edited 24/11/2011
Date ISRCTN assigned 24/11/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central